Clinical

Dataset Information

0

A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy


ABSTRACT: The primary research objective is to demonstrate that subjects taking OXN PR have improvement in symptoms of constipation as measured by the Bowel Function Index (BFI) compared to subjects taking OxyPR tablets alone with cancer and non-cancer related pain without reducing the effectiveness of pain relief as measured by the Brief Pain Inventory (BPI).

DISEASE(S): The Intended Indication Is: severe Pain, Which Can Be Adequately Managed Only With Opioid Analgesics. The Opioid Antagonist Naloxone Is Added To Counteract Opioid-induced Constipation By Blocking The Action Of Oxycodone At Opioid Receptors Locally In The Gut.,Pain,Cancer Pain,Constipation,The Intended Indication Is:severe Pain, Which Can Be Adequately Managed Only With Opioid Analgesics. The Opioid Antagonist Naloxone Is Added To Counteract Opioid-induced Constipation By Blocki...

PROVIDER: 2113147 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2092445 | ecrin-mdr-crc
2024-09-12 | GSE267265 | GEO
2024-09-12 | GSE267264 | GEO
2021-01-09 | E-MTAB-9987 | biostudies-arrayexpress
2020-01-23 | GSE115565 | GEO
2023-05-18 | GSE232804 | GEO
| PRJNA1110771 | ENA
| PRJNA1110772 | ENA
2007-09-01 | GSE8911 | GEO
2024-06-25 | GSE242389 | GEO